Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-130239
Filing Date
2024-11-22
Accepted
2024-11-22 16:30:09
Documents
2
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3421
2 EX-24 mdgl-ex24.htm EX-24 11818
  Complete submission text file 0000950170-24-130239.txt   16843
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MADRIGAL PHARMACEUTICALS, INC. FOUR TOWER BRIDGE 200 BARR HARBOR DR 200 WEST CONSHOHOCKEN PA 19428
Business Address
Huntsman Carole (Reporting) CIK: 0002001571 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 241490187